Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ECULIZUMAB vs RAVULIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ECULIZUMAB vs RAVULIZUMAB: Safety Overview

Metric ECULIZUMAB RAVULIZUMAB
Total FAERS Reports 44,190 118
Deaths Reported 4,626 11
Death Rate 10.5% 9.3%
Hospitalizations 12,421 89
Average Patient Age 42.6 yrs 48.4 yrs
% Female Patients 59.5% 56.3%
Manufacturer Alexion Pharmaceuticals Inc. Alexion Pharmaceuticals Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription N/A